Brief: Herantis Pharma H1 net loss increases to EUR 13.6 million

Herantis Pharma Oyj

19/08/2015 08:21

Aug 19 (Reuters) - Herantis Pharma Oyj  HRTIS.HE : 
    * H1 revenue 1,200 euros ($1,328.16) versus 0.0 euros year ago 
    * H1 loss for period 13.6 million euros versus loss 2.4 million euros year ago 
    * Financial position is expected to be positive at end of period 
    * Says intends to submit clinical trial applications to regulatory authorities by end of 
2015 
    * Says aims at obtaining clinical trial approvals for Lymfactin by end of 2015 
 
Source text for Eikon:  ID:nHUGb8mFwv  
     
Further company coverage:  HRTIS.HE  
 
($1 = 0.9035 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))